These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J. Arthritis Care Res (Hoboken); 2019 Jun 27; 71(6):703-716. PubMed ID: 31021540 [Abstract] [Full Text] [Related]
12. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis. Thomas J, Kuthyar S, Shantha JG, Angeles-Han ST, Yeh S. Ann Eye Sci; 2021 Jun 27; 6():. PubMed ID: 34131629 [Abstract] [Full Text] [Related]
18. Juvenile idiopathic arthritis-associated uveitis. Qian Y, Acharya NR. Curr Opin Ophthalmol; 2010 Nov 27; 21(6):468-72. PubMed ID: 20729734 [Abstract] [Full Text] [Related]
19. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series. La Torre F, Cattalini M, Teruzzi B, Meini A, Moramarco F, Iannone F. BMC Res Notes; 2014 May 24; 7():316. PubMed ID: 24886032 [Abstract] [Full Text] [Related]
20. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, Hoeft S, Walscheid K, Lavric M, Foell D, Minden K. Rheumatology (Oxford); 2019 Jun 01; 58(6):975-986. PubMed ID: 30590748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]